EUVIMEDEUVIMED entdecken
Crossref

Intestinal barrier healing is superior to transmural healing to prevent disease progression in clinical remittent patients with inflammatory bowel disease

Till Orlemann, Dana Zimmermann, Hannah Hübner, Raja Atreya iD, Julia Bodenschatz, Daniele Noviello iD, Francesco Vitali, Deike Strobel, Rolf Janka, Wolfgang Uter, Arndt Hartmann, Markus F Neurath und 1 weitere

Journal of Crohn's and Colitis · 09.01.2026 · 20 (1)

DOI: 10.1093/ecco-jcc/jjaf232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Crohn's and Colitis, online erschienen am 26.12.2025. Verfasst von Till Orlemann und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen 91054, Germany. Hauptthemen laut MEDLINE: Wound Healing, Crohn Disease, Colitis, Ulcerative, Intestinal Mucosa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Achieving endoscopic remission is a key therapeutic goal in inflammatory bowel disease (IBD) that is associated with improved disease outcome. Transmural and intestinal barrier healing represent emerging targets, as they have similarly been associated with favourable disease behaviour. To date, no study has compared these novel end-points and their impact on avoiding deleterious disease outcome.

Methods

Clinically remittent IBD patients underwent ileocolonoscopy with assessment of intestinal barrier function by endomicroscopy. Transmural healing was assessed by magnetic resonance imaging or intestinal ultrasonography. Endoscopic and histologic disease activity were prospectively assessed along established scores. During subsequent follow-up (FU), patients were closely monitored for disease activity and major adverse outcomes (MAO): Disease flares, IBD-related hospitalization/surgery, initiation or escalation of systemic steroid, immunosuppressive or targeted advanced therapy.

Results

Eighty patients (47 Crohn’s disease [CD], 33 ulcerative colitis [UC]) were included. During a mean FU of 34 (CD) and 18 (UC) months, 72% of CD and 85% of UC patients experienced MAO. Intestinal barrier healing exhibited the highest accuracy for predicting MAO-free survival in UC and CD patients and outcompeted transmural healing for predicting the further disease course. Both barrier healing and transmural healing showed higher diagnostic accuracy in forecasting the future course of disease when compared to endoscopic and histologic remission.

Conclusion

Intestinal barrier healing is superior to transmural healing to prevent disease progression in clinical remittent IBD patients while both barrier and transmural healing showed superiority over endoscopic and histologic remission. Hence, barrier and transmural healing are emerging end-points potentially refining disease monitoring and outcome prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingCrohn DiseaseColitis, UlcerativeIntestinal MucosaInflammatory Bowel DiseasesHumansMaleFemaleAdultDisease ProgressionColonoscopyMiddle AgedProspective StudiesMagnetic Resonance ImagingUltrasonographyRemission InductionYoung Adult

Autor:innen und Institutionen

  • Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen 91054, Germany.
  • Department of Medicine 1, Ludwig Demling Endoscopy Center of Excellence, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen 91054, Germany.
  • Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen 91054, Germany.
  • Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen 91054, Germany.
  • Institute for Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen 91054, Germany.

ORCID-Profile: Raja Atreya, Daniele Noviello

Zitieren

APA

Orlemann, T., Zimmermann, D., Hübner, H., Atreya, R., Bodenschatz, J., Noviello, D., Vitali, F., Strobel, D., Janka, R., Uter, W., Hartmann, A., Neurath, M. F., & Rath, T. (2026). Intestinal barrier healing is superior to transmural healing to prevent disease progression in clinical remittent patients with inflammatory bowel disease. Journal of Crohn's and Colitis, 20(1). https://doi.org/10.1093/ecco-jcc/jjaf232

Vancouver

Orlemann T, Zimmermann D, Hübner H, Atreya R, Bodenschatz J, Noviello D, et al. Intestinal barrier healing is superior to transmural healing to prevent disease progression in clinical remittent patients with inflammatory bowel disease. Journal of Crohn's and Colitis. 2026;20(1). doi:10.1093/ecco-jcc/jjaf232

BibTeX
@article{Orlemann2026,
  author = {Orlemann, Till and Zimmermann, Dana and Hübner, Hannah and Atreya, Raja and Bodenschatz, Julia and Noviello, Daniele and Vitali, Francesco and Strobel, Deike and Janka, Rolf and Uter, Wolfgang and Hartmann, Arndt and Neurath, Markus F and Rath, Timo},
  title = {Intestinal barrier healing is superior to transmural healing to prevent disease progression in clinical remittent patients with inflammatory bowel disease},
  journal = {Journal of Crohn's and Colitis},
  year = {2026},
  volume = {20},
  number = {1},
  doi = {10.1093/ecco-jcc/jjaf232}
}
Kostenlos starten →